Retinal Degeneration Fund

About

Retinal Degeneration Fund makes mission-related investments in therapeutic companies with projects nearing clinical testing.

Raleigh,North Carolina,United States
https://www.retinaldegenerationfund.org

Highlights

Details

Industries: Business Development,Financial Services,Therapeutics
Founded date: Jan 1, 2018
Operating Status: Active
Also Known As: RD Fund
Investor Type: CVC

Retinal Degeneration Fund helps in accelerating life-changing outcomes for people with retinal degenerations through direct mission-related investments in therapeutic companies.

The Retinal Degeneration Fund (RD Fund) is a not-for-profit subsidiary of the Foundation Fighting Blindness launched in 2018.

Investments

Number of Investments

Number of Lead Investments

7

1

Retinal Degeneration Fund has made 7 investments. Their most recent investment was on Sep 14, 2022, when SparingVision raised €75M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 14, 2022 SparingVision	Series B	€75M	Biotechnology	—
Jun 15, 2022 Nacuity Pharmaceuticals	Series B	$16.50M	Health Care	—
Jan 5, 2022 SalioGen Therapeutics	Series B	$115M	Biotechnology	—
Sep 22, 2021 Opus Genetics	Seed	$19M	Health Care	Yes
May 18, 2021 Vedere Bio ll	Series A	$77M	Biotechnology	—